GREAT POINT PARTNERS LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,233,123
-11.6%
1,458,070
-0.5%
4.41%
-17.7%
Q2 2023$27,398,324
+10.2%
1,465,151
+8.1%
5.36%
+9.9%
Q1 2023$24,867,021
-12.6%
1,355,151
-5.7%
4.88%
-12.4%
Q4 2022$28,444,066
+275.3%
1,436,569
+356.1%
5.58%
+205.5%
Q3 2022$7,579,000315,0001.82%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders